WO2017126132A1 - Collagen peptide-containing composition - Google Patents

Collagen peptide-containing composition Download PDF

Info

Publication number
WO2017126132A1
WO2017126132A1 PCT/JP2016/052221 JP2016052221W WO2017126132A1 WO 2017126132 A1 WO2017126132 A1 WO 2017126132A1 JP 2016052221 W JP2016052221 W JP 2016052221W WO 2017126132 A1 WO2017126132 A1 WO 2017126132A1
Authority
WO
WIPO (PCT)
Prior art keywords
pectin
proteoglycan
composition
ceramide
weight
Prior art date
Application number
PCT/JP2016/052221
Other languages
French (fr)
Inventor
Megumi OKADA
Takako IMAO
Naoki Kasajima
Noriko Matsui
Original Assignee
Suntory Holdings Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Limited filed Critical Suntory Holdings Limited
Priority to CN201680083146.4A priority Critical patent/CN108697614B/en
Priority to PCT/JP2016/052221 priority patent/WO2017126132A1/en
Priority to SG11201806021QA priority patent/SG11201806021QA/en
Publication of WO2017126132A1 publication Critical patent/WO2017126132A1/en
Priority to HK18116081.6A priority patent/HK1256943A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to a collagen peptide- containing composition.
  • the present inventio relates to a composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin, and a method of inhibiting generation of an aggregate or a precipitate in a composition containing a collagen peptide, a proteoglycan, and a ceramide.
  • Collagen peptide has a wide variety of effects such as a skin beautifying effect for improving the skin moisture retention property and skin elasticity, and an effect of improving the blood fluidity, and accordingly, in recent years, collagen peptide has been contained in very many beverages, food products, cosmetics, and the like.
  • proteoglycan has a capacity of activating the metabolisms of skin and has a high moisture retention property, and thus proteoglycan has been widely recognized among general consumers as a skin beautifying component and has been contained in various types of products.
  • ceramide has been known to have a skin protection action and an effect of preventing rough skin.
  • proteoglycan, and the ceramide have effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore,
  • compositions containing functional components such as collagen peptide beverages are often employed. This is because in beverages, the components can be added at a higher content compared with cases of using capsules, tablets, and the like, because beverages can be easily ingested, and because the commercial value can be improved by selecting acidulants, sweeteners, and the like.
  • a problem of generation of aggregates and precipitates may arise.
  • the problem to be solved by the present invention is to provide a composition in which generation of . aggregates and precipitates is inhibited.
  • the present invention relates to, but not limited to, the following:
  • proteoglycan a ceramide, and a pectin.
  • composition according to item 1) which is liquid.
  • composition according to item 1) or 2), wherein a content of the proteoglycan is 0.0001 to 0.05 w/v%.
  • composition according to any one of items 1) to 4) wherein a ratio of the weight of the proteoglycan to the weight of the pectin (proteoglycan weight : pectin weight) is 1:1 to 1:800.
  • a method of inhibiting generation of an aggregate or a precipitate in a composition containing a collagen peptide, a proteoglycan, and a ceramide including the step of adding a pectin to the composition.
  • proteoglycan to the weight of the pectin added is 1:1 to 1:800.
  • composition according to any one of items 1) to 10), wherein the composition is labeled indication of efficacy of the collagen peptide, the proteoglycan, the ceramide, or the pectin .
  • composition according to item 14), wherein the indication is moisture retention, skin protection, prevention of rough skin, or improvement of skin flabbiness.
  • a method of producing a composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin including the steps of: formulating a raw material containing a collagen peptide, a proteoglycan, a ceramide, and a pectin; and sterilizing and filling the formulated composition.
  • Collagen peptide used in the present invention can be obtained by hydrolyzing a collagen or a modified collagen such as gelatin by using an enzyme, an acid, an alkali, and the like, however, its origin and the production method are not particularly limited.
  • the collagen or gelatin to be used as the raw material may be derived from bovine, swine, chickens, fish, and the like, and one or two or more of them can be used as the raw material.
  • the enzyme used for preparation of a collagen peptide may be an enzyme capable of cleaving peptide bonds of collagen or gelatin, and examples of such an enzyme include collagenase, papain, bromelain, actinidin, ficin, cathepsin, pepsin, chymosin, trypsin, and an enzyme preparation obtained by mixing the enzymes.
  • hydrochloric acid sulfuric acid, and nitric acid
  • alkali sodium hydroxide, calcium hydroxide, and the like can be used, for example .
  • an aqueous solution of hydrolyzed collagen peptide may be used without treatment, or a powder obtained from the aqueous solution of a collagen peptide by drying may be used.
  • collagen peptide processed by purification usually used for the aqueous
  • solution may be used in the form of an aqueous solution, powder, or the like.
  • the effect of the present invention would not be affected or influenced by which of the above forms is employed.
  • the average molecular weight of the collagen peptide is also not particularly limited. However, the in vivo absorbability of a collagen peptide may degrade more as the average molecular weight becomes more and collagen peptide may be easily coagulated at low temperatures depending on the concentration, while if the average molecular weight is small, the in vivo absorbability increases, but bitterness, acridity, and the like, which are unique to peptides, may come out.
  • the average molecular weight of a collagen peptide used in the present invention is preferably 300 to 10,000, more preferably 500 to 9,000, yet more preferably 500 to 6,000.
  • the average molecular weight may be 1,000 to 8,700.
  • the term "average molecular weight" of a collagen peptide herein refers to a weight average molecular weight, which has a value measured by a Photographic and
  • PAGI Gelatin Industries
  • a commercial product may be used as the collagen peptide, and collagen peptide with a preferable molecular weight can be used.
  • collagen peptide with a preferable molecular weight
  • examples of such collagen peptide that can be used include commercial products such as "Nippi peptide PRA” (of Nippi, Inc.), “Water-Soluble Collagen Peptide SS” (of KYOWA HAKKO BIO CO., LTD.) "Collagen Peptide SCP” (of Nitta Gelatin Inc.), and “HACP” (of JELLICE) .
  • one type of collagen peptide may be used alone or two types or more collagen peptides may be used in combination.
  • the total content of the collagen peptide in the composition of the present invention can be changed according to the purpose of use of the
  • composition containing collagen peptide is typically 1.0 to 35 w/v%, preferably 1.0 to 25 w/v%, and more preferably 2.0 to 20 w/v%.
  • Proteoglycan is a generic name of a compound in which glycosaminoglycan (mucopolysaccharide) such as chondroitin sulfate and dermatan sulfate is covalently bonded to protein as the core.
  • glycosaminoglycan molysaccharide
  • chondroitin sulfate and dermatan sulfate is covalently bonded to protein as the core.
  • Proteoglycan exists in connective tissues of animals such as cartilage and skin, and it is a substance necessary for maintaining the structure of the tissues.
  • proteoglycan examples include aggrecan, versican, neurocan, brevican, decorin, biglycari, testican, perlecan, dystroglycan, agrin, . and claustrin.
  • the type, origin, and production method of the proteoglycan used in the present invention are not
  • proteoglycan may be used alone, or a combination of two or more of them may be used. Among them, aggrecan is preferable, and aggrecan may be used alone or a combination with other proteoglycan may be used.
  • Animals that can be used as an origin of the proteoglycan is not particularly limited, and proteoglycan derived from animals such as mammals (bovine, swine, and the like), birds (chickens and the like), fish
  • molluscas cuttlefish, octopus, and the like
  • proteoglycan derived from one or two or more types of animals can be used.
  • a proteoglycan derived from salmon is preferable and a proteoglycan derived from nasal cartilage of salmon is particularly preferable, and proteoglycan derived from salmon may be used alone or a combination thereof with other proteoglycan may be used.
  • any known methods such as an extraction method and the like that uses solvents such as water, acid (acetic acid or the like) , alkali (sodium hydroxide, potassium hydroxide, and the like) , and alcohols may be used. Purification is not
  • the molecular weight of the proteoglycan is usually several tens of thousands to several tens of millions.
  • the molecular weight of the proteoglycan used in the present invention is not particularly limited either, and is preferably 100,000 to 2,000,000.
  • proteoglycan containing a proteoglycan may be used without treatment, or a powder thereof obtained by drying may be used.
  • proteoglycan processed by purification usually used for the aqueous solution may be used in the form of an aqueous
  • composition of the present invention can. be changed according to the purpose of use of the composition containing
  • proteoglycan is typically 0.0001 to 0.05 w/v%, preferably 0.001 to 0.05 w/v%, more preferably 0.002 to 0.02 w/v% .
  • any known method may be used, and specifically, a gel chromatography molecular weight fractionation method can be used, for example. More specifically, molecular weight fractionation is carried out by using gel chromatography, a proteoglycan standard reagent (Proteoglycan, from Salmon Nasal Cartilage (of Wako Pure Chemical Industries, Ltd.) is used for determination or a dried product of a fraction with the molecular weight of
  • Ceramide Ceramide is one of sphingolipids constituted by sphingosine and lipid bonded by amide bonding.
  • hydrophilic groups are bonded to ceramide to form a primary compound sphingolipid (a sphingolipid containing phosphorous, sulfur, amino acid, and sugar in its molecule) .
  • sphingomyelin in which phosphocholine is bonded to ceramide
  • glycoside bonding A substance in which sugar is bonded to ceramide by glycoside bonding is glycosphingoside.
  • Glycosphingoside exists widely in animals, plants, fungi, and the like, and is represented b cerebroside, in which monosaccharide is bonded to ceramide.
  • glucosylceramide constituted by glucose bonded to ceramide and galactosylceramide constituted by galactose bonded to ceramide exist, and in plants and fungi, ⁇ -glucosylceramide constituted by glucose bonded to ceramide by ⁇ -glycoside bonding exists.
  • Ceramide plays a significant role in exerting a skin moisture retention function and a skin barrier function in the horny layer, which is the outermost layer of the skin. In addition, it has been known that ceramide exerts a skin
  • Ceramide used in the present invention is not
  • ceramide examples include
  • ceramide ceramide, ceramide saccharide, sphingophospholipid, and glycosphingolipid, and ceramide saccharide is particularly preferable.
  • ceramide saccharide examples include
  • glucosylceramide is particularly preferable. Examples of commercial products that can be used as ceramide of the
  • present invention include commercial products such as ORYZA CERAMIDE WSP (of Oryza Oil & Fat Chemical Co., Ltd.) and Milk Ceramide MC-5 SD30 (of MEGMILK SNOW BRAND Co., Ltd).
  • Examples of the raw materials of the ceramide used in the present invention include, but not limited to, the skin and the brain of animals such as swine, bovine, horses, and the like; the viscera and the head of fish, molluscas;
  • arthropods hen eggs; and milk; and plants such as wheat, rye, rice, soybean, corn, millet, konjak, spinach, fungi (Grifola frondosa, Pleurotus cornucopiae, and the like) , grape, cherry, Citrus junos, olive, Perilla, shekwasha, prune, and beet sugar.
  • ceramide derived from rice is preferable.
  • the ceramide used in the present invention may be a natural
  • Extracts from animals and plants containing ceramide and preparations containing ceramide with the content ratio increased by various methods may be used, and the purity of the ceramide is not particularly limited, and a highly pure purified ceramide and crude ceramide with a low purity may be used.
  • ceramide containing ceramide may be used without treatment, or a powder thereof obtained by drying may be used.
  • solution may be used in the form of an aqueous solution, powder, or the like.
  • the effect of the present invention would not be affected or influenced by which of the above forms is employed.
  • the total content of the ceramide in the composition of the present invention can be changed according to the purpose of use of the composition containing ceramide, and is typically 0.0001 to 0.1 w/v%, preferably 0.0005 to 0.05 w/v%, more preferably 0.001 to 0.005 w/v% .
  • Pectin is a polymeric carbohydrate, which is particularly contained in leafs, stems, and fruits of plants as a component for bonding cells in the body of plants. Pectin is
  • polygalacturonic acid in which D-galacturonic acid is bonded by a-1,4 bonding as a straight chain, and includes protopectin, pectinic acid, amidated pectin, pectic acid, and the like.
  • pectin can be used in acidic food, it is used as a gelling agent for jams and jellies and as a lactoprotein stabilizer for yogurt drinks.
  • pectin generally includes high methoxyl (HM) pectins with an esterification degree of 50% or more and low methoxyl (LM) pectins with an esterification degree of less than 50%, and is not particularly limited in the present invention although the gelling conditions and gelling properties for them are different.
  • HM high methoxyl
  • LM low methoxyl
  • Pectin used in the present invention can be obtained by extraction from plant materials, and the origin and the production method are not particularly limited.
  • the pectin that can be used as the raw material include citrus fruits (orange, grapefruit, Citrus junos, lime, lemon, and the like), apples, beet sugar, and the like.
  • Various regions such as leafs, stem, fruits, and fruit skin contain pectin, and the region used in the present invention is not particularly limited, and the whole fruit may be used by selecting a specific region.
  • the breed is not particularly limited.
  • pectin derived from fruit skins of citrus fruits can be preferably used.
  • Examples of commercial products of the pectin that can be used include P-27 (of Nitta Gelatin Inc.), and Neosoft P (of Taiyo Kagaku Co., Ltd.).
  • the production method of the pectin used in the present invention is not particularly limited, and the pectin used in the present invention can be produced from plant raw materials by known methods by performing processes of extraction,
  • an aqueous solution containing pectin may be. used without treatment, or a powder thereof obtained by drying may be used.
  • solution may be used in the form of an aqueous solution, powder, or the like.
  • the effect of the present invention would not be affected or influenced by which of the above forms is employed.
  • the total content of the pectin in the composition of the present invention can be changed according to the purpose of use of the composition containing pectin, and is typically 0.05 to 0.8 w/v%, preferably 0.05 to 0.5 w/v%, more preferably 0.1 to 0.5 w/v%, yet more preferably 0.1 to 0.3 w/v%.
  • Ratio of proteoglycan weight to pectin weight In the present invention, a pectin is added in order to inhibit generation of aggregates and precipitates derived from a collagen peptide, a proteoglycan, and a ceramide in the composition.
  • the ratio of the proteoglycan weight to the pectin weight is not particularly limited, and the ratio of the proteoglycan weight to the pectin weight in the composition (proteoglycan weight : pectin- weight) is 1:1 or more, preferably 1:2 or more, more
  • the ratio of the proteoglycan weight to the pectin weight (proteoglycan weight : pectin weight) in the composition is 1:1 to 1:800, preferably 1:2 to 1:500, more preferably 1:5 to 1:100, yet more preferably 1:10 to 1:50.
  • the pH of the composition of the present invention is not particularly limited, however, considering the above- described characteristic, it is preferable if the pH thereof be low.
  • the low-pH region is typically 2.5 to 5.0, preferably 3.0 to 4.5, more preferably 3.3 to 4.0. In another
  • the pH range is 2.5 to 3.4 and preferably 2.8 to 3.2, or is 3.6 to 5.0 and preferably 3..8 to 4.5.
  • composition containing a collagen a peptide, a proteoglycan, a ceramide, and a pectin.
  • composition is herein not particularly limited.
  • compositions examples include a solid composition and a liquid composition.
  • the composition is a liquid composition based on water, more preferably an aqueous liquid composition, and examples of such a liquid composition include an aqueous solution, a suspension, and a dispersion.
  • a liquid composition based on water, more preferably an aqueous liquid composition, and examples of such a liquid composition include an aqueous solution, a suspension, and a dispersion.
  • precipitation or separation may occur in a collagen-containing aqueous solution during its storage, and the solution the solution is shaken when it is used to disperse or dissolve the precipitate or separation matter. Accordingly, the
  • composition of the present invention includes compositions in which tolerable precipitation, separation, cloudiness, and the like.
  • a medium other than water such as alcohol may be included in the composition where necessary.
  • composition of the present invention may further include a plant material according to its purpose of use.
  • a plant material materials including components with
  • beautifying effects are preferable, and examples of such a plant material include extracts of Piperaceae (e.g., Piper longum extract), flax lignan ( secoisolariciresinol diglucoside, matairesinol , pinoresinol, isolariciresinol, and the like), flaxseed extract, cherry flower extract, Lonicera caerulea extract, ginger extract, cinnamon extract, soy isoflavone, rose flower extract, ceramide derived from plants (wheat, rice , embryo, konjak, corn embryo, pineapple) , lotus embryo extract, tencha tea extract, Pyracantha fortuneana extract, pine bark extract, Maca extract, artichoke leaf extract, Isodon
  • Piperaceae e.g., Piper longum extract
  • flax lignan secoisolariciresinol diglucoside, matairesinol , pinoresinol, isolariciresinol, and the like
  • j.aponicus extract Hypericum extract, sage extract, linden extract, Momordica grosvenori extract, Houttuynia cordata extract, neem leaf extract, gotu kola extract, amla extract, Mangosteen pericarp extract, aronia extract, tochu tea leaf extract, adlay extract, ginseng extract, fruit seed extract, unpolished violet rice extract, Alpinia zerumbet leaf extract, Star fruit leaf extract, and aloe extract, and one or two or more of them can be used as the component (s) of the
  • composition of the present invention is a composition of the present invention.
  • the Piper longum extract, the flaxseed extract, the cherry flower extract, and the Lonicera caerulea extract can be obtained by concentrating juice or extract obtained by pressing and solvent extraction from the fruit cluster of
  • Extracts can be similarly obtained by from plant raw materials.
  • solvents such as water, methanol, ethanol, isopropanol can be used. Although not absolutely necessary, purification may be performed.
  • composition of the present invention can include further additional components as long as they would not affect the effect of the present invention.
  • additional components include vitamins, minerals, nutrient components, perfumes, antioxidants, pigments, preservatives, seasoning, sweeteners, acidulants, pH adjustors, stabilizers, isotonizing agents, emulsifiers, buffers, enrichments, and antiseptics .
  • composition of the present invention can be expected to exert an excellent beautifying effect derived from the components such as collagen peptide
  • the composition of the present invention can be provided with explicitly or implicitly indicating that it is used for preventing rough skin, retention of skin moisture, protection of skin,
  • composition of the present invention can be provided in a form of food and drink, pharmaceutical product, cosmetics, and the like. If the composition of the present invention is provided as food and drink, the composition can be provided, but not limited to, in the form of health food such as functional food products, supplements, drinking agents
  • solution and suspension are included, or may be provided in the form of soft drinks, tea beverages, lactic acid bacteria beverages, and the like.
  • composition of the present invention can be filled in a container.
  • the form of the container is not
  • composition of the present invention can be filled in sealed containers such as bottles, cans, paper packs, polyethylene terephthalate (PET) bottles,
  • An indication can be labeled to the container.
  • an indication indicating the efficacy of a collagen peptide, a proteoglycan, a ceramide, or a pectin can be given.
  • Examples of such description of the indication include uses such as for moisture retention, for skin protection, for prevention of rough skin, for improvement of flabby skin, and the like.
  • the indication may be given to the composition itself or may be given to the container or package of the composition.
  • composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin is used as the raw material, and the steps of adding acidulants, sweeteners, and the like to the composition and sterilizing and filling the resulting product are performed to produce the drink.
  • Sterilization conditions may satisfy the conditions provided by the Food Sanitation Law, and various sterilization devices such as plate type heat exchangers, tube type heat exchangers, pasteurizers can be used.
  • the filling method is not
  • hot-pack filling aseptic filling, and the like can be employed.
  • the present invention also relates to a method of
  • the method is characteristic in a point that pectin is added to the composition.
  • the total content of the pectin in the composition is not particularly limited, and is typically 0.05 to 0.8 w/v%, preferably 0.05 to 0.5 w/v%, more preferably 0.1 to 0.5 w/v%, yet more preferably 0.1 to 0.3 w/v% .
  • the ratio of the proteoglycan weight to the pectin weight (proteoglycan weight : pectin weight) in the composition is not particularly limited either, and is typically 1:1 or more, preferably 1:2 or more, more preferably 1:5 or more, yet more preferably 1:10 or more, and is typically 1:800 or less, preferably 1:500 or less, more preferably 1:100 or less, yet more preferably 1:50 or less.
  • the ratio of the proteoglycan weight to the pectin weight (proteoglycan weight : pectin weight) in the composition is, but not limited to, 1:1 to 1:800,
  • the method and the timing of adding a pectin to the composition are not particularly limited, as long as pectin is added in the composition at any one or more of the stages of its production.
  • the other components may be added to, or mixed with, a composition containing a pectin, or a pectin may be added to, or mixed with, a composition
  • composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin for inhibiting precipitation that may occur with time and for inhibiting coagulation of the
  • the raw materials except the acidulant were added to water, dissolved therein, then the resulting mixture was adjusted with the acidulant to control the pH to 3.50 ⁇ 0.20, and the volume determination was performed.
  • Table 1 shows the final compounding amount of the acidulant required for adjustment of the pH and the like.
  • the obtained solution was sterilized by a plate type heat exchanger, the sterilized solution was dispensed in brown bottles by 50 mL each, and the bottles were tightly stopped to obtain beverages (1) and (2).
  • the average molecular weight of the collagen peptide used in the Examples was 3,000, the molecular weight of the
  • proteoglycan derived from nasal cartilage of salmon used in the Examples was about 450,000, glucosylceramide derived from rice was used as ceramide, Piper longum was used as the plant extract, and HM pectin derived from fruit skins of citrus fruits was used as pectin.
  • compositions and the evaluation results are shown in Table 1.
  • evaluation criteria are shown in .
  • beverages were produced according to the compounds shown in Table 3.
  • the raw materials except the acidulant were added to water, dissolved therein, then the resulting mixture was adjusted with the acidulant to control the pH to 3.50+0.20, and the volume was determined to be 1,000 ml.
  • Table 3 shows the final compounding amount of the acidulant required for adjustment of the pH and the like.
  • the obtained solution was dispensed in brown bottles by 50 mL each, and then dip sterilization was performed to obtain beverages (3) and (16). Note that the same collagen peptide, proteoglycan, ceramide, plant extract, and pectin as those in Example 1 were used.
  • the beverages were preserved 5°C for 4 days, and the amount of precipitate, the properties of the precipitate, and the flavor and the texture were evaluated by visual observation and by sensory tests by 3 expert panelists.
  • a pectin is added to the composition containing a collagen peptide, a proteoglycan, and a ceramide, generation of aggregates and. precipitates can be inhibited. Because pectin is a naturally derived component, the safety is high. Therefore, according to the present invention, an excellent external appearance of the collagen peptide-containing composition can be maintained by an easy and safe method, and thus the present invention has a high industrial applicability.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

Provided is a composition containing a collagen peptide, a proteoglycan, and a ceramide, which is capable of inhibiting generation of aggregates and precipitates. A pectin is added to the composition containing a collagen peptide, a proteoglycan, and a ceramide.

Description

DESCRIPTION
Title of Invention
COLLAGEN PEPTIDE-CONTAINING COMPOSITION . Technical Field
[0001] The present invention relates to a collagen peptide- containing composition. Specifically, the present inventio relates to a composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin, and a method of inhibiting generation of an aggregate or a precipitate in a composition containing a collagen peptide, a proteoglycan, and a ceramide.
Background Art
[0002] In recent years, beauty and inhibition of skin aging have attracted attention from women. Collagen peptide has a wide variety of effects such as a skin beautifying effect for improving the skin moisture retention property and skin elasticity, and an effect of improving the blood fluidity, and accordingly, in recent years, collagen peptide has been contained in very many beverages, food products, cosmetics, and the like. In addition, proteoglycan has a capacity of activating the metabolisms of skin and has a high moisture retention property, and thus proteoglycan has been widely recognized among general consumers as a skin beautifying component and has been contained in various types of products. Further, ceramide has been known to have a skin protection action and an effect of preventing rough skin. [0003] As described above, the collagen peptide, the
proteoglycan, and the ceramide have effects related to beauty such as skin moisture retention effect, skin protection effect, and skin flabbiness improving effect. Therefore, these
components are often contained in food, beverage,
pharmaceutical products, cosmetic products, and the like.
[0004] As a composition containing functional components such as collagen peptide, beverages are often employed. This is because in beverages, the components can be added at a higher content compared with cases of using capsules, tablets, and the like, because beverages can be easily ingested, and because the commercial value can be improved by selecting acidulants, sweeteners, and the like. However, with respect to such a composition containing collagen peptide, a problem of generation of aggregates and precipitates may arise. As . techniques for inhibiting generation of aggregates and
precipitates in compositions, a plurality of methods has been reported (JP 3416102 Bl, JP 5021909 Bl) .
Summary of Invention
Technical Problem
[0005] In a composition containing collagen peptide and the like, aggregates and precipitates may be generated and the appearance of the composition may degrade. Due to the above- described problem in terms of appearance, problems of
degradation of product image and degradation of commercial value may arise concerning compositions containing collagen peptide and the like.
[0006] The problem to be solved by the present invention is to provide a composition in which generation of . aggregates and precipitates is inhibited.
Solution to Problem
[0007] The inventor has industriously carried out
researches, and as a result, has found that aggregates and precipitates are generated in compositions containing a collagen peptide, a proteoglycan, and a ceramide and
generation of such aggregates and precipitates can be
inhibited by addition of a pectin.
[0008] Specifically, the present invention, relates to, but not limited to, the following:
1) . A composition containing a collagen peptide, a
proteoglycan, a ceramide, and a pectin.
2) . The composition according to item 1), which is liquid.
3) . The composition according to item 1) or 2), wherein a content of the proteoglycan is 0.0001 to 0.05 w/v%.
4) . The composition according to any one of items 1) to 3), wherein a content of the pectin is 0.05 to 0.8 w/v% .
5) . The composition according to any one of items 1) to 4) , wherein a ratio of the weight of the proteoglycan to the weight of the pectin (proteoglycan weight : pectin weight) is 1:1 to 1:800.
6) . The composition according to any one of items 1) to 5), wherein a content of the collagen peptide is 1.0 to 25 w/v%.
7) . The composition according to any one of items 1) to 6), wherein a content of the ceramide is 0.0001 to 0.1 w/v% .
8) . The composition according to any one of items 2) to 7), wherein the composition has a PH of 2.5 to 5.0. 9) .. The composition according to any one of items 1) to 8), which is for oral use.
10) . The composition according to any one of items 1) to 9), which is for beautiful skin.
11) . A method of inhibiting generation of an aggregate or a precipitate in a composition containing a collagen peptide, a proteoglycan, and a ceramide, the method including the step of adding a pectin to the composition.
12) . The method according to item 11), wherein an amount of the pectin added is 0.05 to 0.8 w/v% based on the total amount of the composition.
13) . The method according to item 11) or 12), wherein the pectin is added so that a ratio of the weight of the
proteoglycan to the weight of the pectin added (proteoglycan weight: pectin weight) is 1:1 to 1:800.
14) . The composition according to any one of items 1) to 10), wherein the composition is labeled indication of efficacy of the collagen peptide, the proteoglycan, the ceramide, or the pectin .
15) . The composition according to item 14), wherein the indication is moisture retention, skin protection, prevention of rough skin, or improvement of skin flabbiness.
16) . A method of producing a composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin, the method including the steps of: formulating a raw material containing a collagen peptide, a proteoglycan, a ceramide, and a pectin; and sterilizing and filling the formulated composition.
17) . The method according to item 16), wherein an amount of the pectin added is 0.05 to 0.8 w/v% based on the total amount of the composition.
18). The method according to item 16) or 17), wherein pectin is added so that a ratio of the weight of the proteoglycan to the weight of the pectin added (proteoglycan weight : pectin weight) is 1:1 to 1:800.
Advantageous Effects of Invention
[0009] According to the present invention, generation of aggregates and precipitates are inhibited by addition of a pectin to a composition containing a collagen peptide, a proteoglycan, and a ceramide.
Description of Embodiments
[0010] 1. Components
1-1. Collagen peptide
Collagen peptide used in the present invention can be obtained by hydrolyzing a collagen or a modified collagen such as gelatin by using an enzyme, an acid, an alkali, and the like, however, its origin and the production method are not particularly limited.
[0011] For example, the collagen or gelatin to be used as the raw material may be derived from bovine, swine, chickens, fish, and the like, and one or two or more of them can be used as the raw material.
[0012] The enzyme used for preparation of a collagen peptide may be an enzyme capable of cleaving peptide bonds of collagen or gelatin, and examples of such an enzyme include collagenase, papain, bromelain, actinidin, ficin, cathepsin, pepsin, chymosin, trypsin, and an enzyme preparation obtained by mixing the enzymes.
[0013] For the acid, hydrochloric acid, sulfuric acid, and nitric acid can be used, for example. For the alkali, sodium hydroxide, calcium hydroxide, and the like can be used, for example .
[0014] In the present invention, an aqueous solution of hydrolyzed collagen peptide may be used without treatment, or a powder obtained from the aqueous solution of a collagen peptide by drying may be used. In addition, collagen peptide processed by purification usually used for the aqueous
solution may be used in the form of an aqueous solution, powder, or the like. The effect of the present invention would not be affected or influenced by which of the above forms is employed.
[0015] The average molecular weight of the collagen peptide is also not particularly limited. However, the in vivo absorbability of a collagen peptide may degrade more as the average molecular weight becomes more and collagen peptide may be easily coagulated at low temperatures depending on the concentration, while if the average molecular weight is small, the in vivo absorbability increases, but bitterness, acridity, and the like, which are unique to peptides, may come out. In consideration of the above points, the average molecular weight of a collagen peptide used in the present invention is preferably 300 to 10,000, more preferably 500 to 9,000, yet more preferably 500 to 6,000. The average molecular weight may be 1,000 to 8,700. The term "average molecular weight" of a collagen peptide herein refers to a weight average molecular weight, which has a value measured by a Photographic and
Gelatin Industries (PAGI) method (gel filtration
chromatography method) .
[0016] A commercial product may be used as the collagen peptide, and collagen peptide with a preferable molecular weight can be used. Examples of such collagen peptide that can be used include commercial products such as "Nippi peptide PRA" (of Nippi, Inc.), "Water-Soluble Collagen Peptide SS" (of KYOWA HAKKO BIO CO., LTD.) "Collagen Peptide SCP" (of Nitta Gelatin Inc.), and "HACP" (of JELLICE) .
[0017] In the present invention, one type of collagen peptide may be used alone or two types or more collagen peptides may be used in combination. The total content of the collagen peptide in the composition of the present invention can be changed according to the purpose of use of the
composition containing collagen peptide, and is typically 1.0 to 35 w/v%, preferably 1.0 to 25 w/v%, and more preferably 2.0 to 20 w/v%.
[0018] 1-2. Proteoglycan
"Proteoglycan" is a generic name of a compound in which glycosaminoglycan (mucopolysaccharide) such as chondroitin sulfate and dermatan sulfate is covalently bonded to protein as the core. Proteoglycan exists in connective tissues of animals such as cartilage and skin, and it is a substance necessary for maintaining the structure of the tissues.
Examples of the proteoglycan include aggrecan, versican, neurocan, brevican, decorin, biglycari, testican, perlecan, dystroglycan, agrin, . and claustrin. [0019] The type, origin, and production method of the proteoglycan used in the present invention are not
particularly limited. For example, any of the above
proteoglycan may be used alone, or a combination of two or more of them may be used. Among them, aggrecan is preferable, and aggrecan may be used alone or a combination with other proteoglycan may be used. Animals that can be used as an origin of the proteoglycan is not particularly limited, and proteoglycan derived from animals such as mammals (bovine, swine, and the like), birds (chickens and the like), fish
(sharks, salmon, and the like), molluscas (cuttlefish, octopus, and the like) , and the like can be used, and further,
proteoglycan derived from one or two or more types of animals can be used. Among them, a proteoglycan derived from salmon is preferable and a proteoglycan derived from nasal cartilage of salmon is particularly preferable, and proteoglycan derived from salmon may be used alone or a combination thereof with other proteoglycan may be used. For the production method, any known methods such as an extraction method and the like that uses solvents such as water, acid (acetic acid or the like) , alkali (sodium hydroxide, potassium hydroxide, and the like) , and alcohols may be used. Purification is not
absolutely necessary, and for purification, known methods such as desalination, molecular weight fractionation, and the like may be used. The molecular weight of the proteoglycan, is usually several tens of thousands to several tens of millions. The molecular weight of the proteoglycan used in the present invention is not particularly limited either, and is preferably 100,000 to 2,000,000.
[0020] In the present invention, an aqueous solution
containing a proteoglycan may be used without treatment, or a powder thereof obtained by drying may be used. In addition, proteoglycan processed by purification usually used for the aqueous solution may be used in the form of an aqueous
solution, powder, or the like. The effect of the present invention would not be affected or influenced by which of the above forms is employed.
[0021] The total content of the proteoglycan in the
composition of the present invention can. be changed according to the purpose of use of the composition containing
proteoglycan, and is typically 0.0001 to 0.05 w/v%, preferably 0.001 to 0.05 w/v%, more preferably 0.002 to 0.02 w/v% .
[0022] For the method of measuring the content, any known method may be used, and specifically, a gel chromatography molecular weight fractionation method can be used, for example. More specifically, molecular weight fractionation is carried out by using gel chromatography, a proteoglycan standard reagent (Proteoglycan, from Salmon Nasal Cartilage (of Wako Pure Chemical Industries, Ltd.) is used for determination or a dried product of a fraction with the molecular weight of
10,000 or more and for which existence of acid saccharide and protein has been verified is measured. Note that existence of acid saccharide can be verified by a carbazole-sulfuric acid method, and existence of protein can be verified by measuring the absorbance at about 280 nm.
[0023] 1-3. Ceramide Ceramide is one of sphingolipids constituted by sphingosine and lipid bonded by amide bonding. Various
hydrophilic groups are bonded to ceramide to form a primary compound sphingolipid (a sphingolipid containing phosphorous, sulfur, amino acid, and sugar in its molecule) . For example, sphingomyelin, in which phosphocholine is bonded to ceramide, is known as a primary sphingophospholipid for animals. A substance in which sugar is bonded to ceramide by glycoside bonding is glycosphingoside. Glycosphingoside exists widely in animals, plants, fungi, and the like, and is represented b cerebroside, in which monosaccharide is bonded to ceramide.
As cerebroside, in animals, glucosylceramide constituted by glucose bonded to ceramide and galactosylceramide constituted by galactose bonded to ceramide exist, and in plants and fungi, β-glucosylceramide constituted by glucose bonded to ceramide by β-glycoside bonding exists.
[0024] Ceramide plays a significant role in exerting a skin moisture retention function and a skin barrier function in the horny layer, which is the outermost layer of the skin. In addition, it has been known that ceramide exerts a skin
moisture retention effect by building an intercellular
lamellar structure in the horny layer and that ceramide has a skin protection action and a rough skin prevention effect exerted by the skin moisture retention effect.
[0025] Ceramide used in the present invention is not
particularly limited except that it is a compound having a sphingo-skeleton, and examples of such ceramide include
ceramide, ceramide saccharide, sphingophospholipid, and glycosphingolipid, and ceramide saccharide is particularly preferable. Examples of the ceramide saccharide include
glucosylceramide , galactosylceramide, and the like, and
glucosylceramide is particularly preferable. Examples of commercial products that can be used as ceramide of the
present invention include commercial products such as ORYZA CERAMIDE WSP (of Oryza Oil & Fat Chemical Co., Ltd.) and Milk Ceramide MC-5 SD30 (of MEGMILK SNOW BRAND Co., Ltd).
[0026] Examples of the raw materials of the ceramide used in the present invention include, but not limited to, the skin and the brain of animals such as swine, bovine, horses, and the like; the viscera and the head of fish, molluscas;
arthropods; hen eggs; and milk; and plants such as wheat, rye, rice, soybean, corn, millet, konjak, spinach, fungi (Grifola frondosa, Pleurotus cornucopiae, and the like) , grape, cherry, Citrus junos, olive, Perilla, shekwasha, prune, and beet sugar. Among them, ceramide derived from rice is preferable. The ceramide used in the present invention may be a natural
product or a synthetic product, and the method of extraction and purification of the ceramide is not particularly limited, either. Extracts from animals and plants containing ceramide and preparations containing ceramide with the content ratio increased by various methods may be used, and the purity of the ceramide is not particularly limited, and a highly pure purified ceramide and crude ceramide with a low purity may be used.
[0027] In the present invention, an aqueous solution
containing ceramide may be used without treatment, or a powder thereof obtained by drying may be used. In addition, ceramide processed by purification usually used for the aqueous
solution may be used in the form of an aqueous solution, powder, or the like. The effect of the present invention would not be affected or influenced by which of the above forms is employed.
[0028] The total content of the ceramide in the composition of the present invention can be changed according to the purpose of use of the composition containing ceramide, and is typically 0.0001 to 0.1 w/v%, preferably 0.0005 to 0.05 w/v%, more preferably 0.001 to 0.005 w/v% .
[0029] 1-4. Pectin
Pectin is a polymeric carbohydrate, which is particularly contained in leafs, stems, and fruits of plants as a component for bonding cells in the body of plants. Pectin is
polygalacturonic acid in which D-galacturonic acid is bonded by a-1,4 bonding as a straight chain, and includes protopectin, pectinic acid, amidated pectin, pectic acid, and the like.
Because pectin can be used in acidic food, it is used as a gelling agent for jams and jellies and as a lactoprotein stabilizer for yogurt drinks.
[0030] In a large sense, pectin generally includes high methoxyl (HM) pectins with an esterification degree of 50% or more and low methoxyl (LM) pectins with an esterification degree of less than 50%, and is not particularly limited in the present invention although the gelling conditions and gelling properties for them are different.
[0031] Pectin used in the present invention can be obtained by extraction from plant materials, and the origin and the production method are not particularly limited. Examples of the pectin that can be used as the raw material include citrus fruits (orange, grapefruit, Citrus junos, lime, lemon, and the like), apples, beet sugar, and the like. Various regions such as leafs, stem, fruits, and fruit skin contain pectin, and the region used in the present invention is not particularly limited, and the whole fruit may be used by selecting a specific region. The breed is not particularly limited. In the present invention, pectin derived from fruit skins of citrus fruits can be preferably used. Examples of commercial products of the pectin that can be used include P-27 (of Nitta Gelatin Inc.), and Neosoft P (of Taiyo Kagaku Co., Ltd.). The production method of the pectin used in the present invention is not particularly limited, and the pectin used in the present invention can be produced from plant raw materials by known methods by performing processes of extraction,
filtration, . alcohol precipitation, drying, crushing, and the like.
[0032] In the present invention, an aqueous solution containing pectin may be. used without treatment, or a powder thereof obtained by drying may be used. In addition, pectin processed by purification usually used for the aqueous
solution may be used in the form of an aqueous solution, powder, or the like. The effect of the present invention would not be affected or influenced by which of the above forms is employed.
[0033] The total content of the pectin in the composition of the present invention can be changed according to the purpose of use of the composition containing pectin, and is typically 0.05 to 0.8 w/v%, preferably 0.05 to 0.5 w/v%, more preferably 0.1 to 0.5 w/v%, yet more preferably 0.1 to 0.3 w/v%.
[0034] 1-5. Ratio of proteoglycan weight to pectin weight In the present invention, a pectin is added in order to inhibit generation of aggregates and precipitates derived from a collagen peptide, a proteoglycan, and a ceramide in the composition. In the present invention, the ratio of the proteoglycan weight to the pectin weight is not particularly limited, and the ratio of the proteoglycan weight to the pectin weight in the composition (proteoglycan weight : pectin- weight) is 1:1 or more, preferably 1:2 or more, more
preferably 1:5 or more, and yet more preferably 1:10 or more; and is 1:800 or less, preferably 1:500 or less, more
preferably 1:100 or less, yet more preferably 1:50 or less, for example. Specifically, the ratio of the proteoglycan weight to the pectin weight (proteoglycan weight : pectin weight) in the composition is 1:1 to 1:800, preferably 1:2 to 1:500, more preferably 1:5 to 1:100, yet more preferably 1:10 to 1:50.
[0035] 2. Composition
2-1. pH
Generation of aggregates and precipitates derived from a collagen peptide, a proteoglycan, and a ceramide often becomes problematic in low-pH regions. In the composition of the present invention containing a collagen peptide, a proteoglycan., a ceramide, and a pectin, generation of aggregates and precipitates in low-pH regions can also be inhibited. The pH of the composition of the present invention is not particularly limited, however, considering the above- described characteristic, it is preferable if the pH thereof be low. The low-pH region is typically 2.5 to 5.0, preferably 3.0 to 4.5, more preferably 3.3 to 4.0. In another
embodiments, the pH range is 2.5 to 3.4 and preferably 2.8 to 3.2, or is 3.6 to 5.0 and preferably 3..8 to 4.5.
[0036] 2-2. Composition
The present invention relates to a composition containing a collagen a peptide, a proteoglycan, a ceramide, and a pectin. The term "composition" is herein not particularly limited.
Examples of such a composition include a solid composition and a liquid composition. The composition is a liquid composition based on water, more preferably an aqueous liquid composition, and examples of such a liquid composition include an aqueous solution, a suspension, and a dispersion. In general,
precipitation or separation may occur in a collagen-containing aqueous solution during its storage, and the solution the solution is shaken when it is used to disperse or dissolve the precipitate or separation matter. Accordingly, the
composition of the present invention includes compositions in which tolerable precipitation, separation, cloudiness, and the like. In addition, a medium other than water such as alcohol may be included in the composition where necessary.
[0037] 2-3. Plant material
The composition of the present invention may further include a plant material according to its purpose of use. For the plant material, materials including components with
beautifying effects are preferable, and examples of such a plant material include extracts of Piperaceae (e.g., Piper longum extract), flax lignan ( secoisolariciresinol diglucoside, matairesinol , pinoresinol, isolariciresinol, and the like), flaxseed extract, cherry flower extract, Lonicera caerulea extract, ginger extract, cinnamon extract, soy isoflavone, rose flower extract, ceramide derived from plants (wheat, rice, embryo, konjak, corn embryo, pineapple) , lotus embryo extract, tencha tea extract, Pyracantha fortuneana extract, pine bark extract, Maca extract, artichoke leaf extract, Isodon
j.aponicus extract, Hypericum extract, sage extract, linden extract, Momordica grosvenori extract, Houttuynia cordata extract, neem leaf extract, gotu kola extract, amla extract, Mangosteen pericarp extract, aronia extract, tochu tea leaf extract, adlay extract, ginseng extract, fruit seed extract, unpolished violet rice extract, Alpinia zerumbet leaf extract, Star fruit leaf extract, and aloe extract, and one or two or more of them can be used as the component (s) of the
composition of the present invention.
[0038] The Piper longum extract, the flaxseed extract, the cherry flower extract, and the Lonicera caerulea extract can be obtained by concentrating juice or extract obtained by pressing and solvent extraction from the fruit cluster of
Piper longum, flaxseed or flaxseed meal, cherry flower, the fruit of Lonicera caerulea L. ssp.edulis Hulten, respectively. Other extracts can be similarly obtained by from plant raw materials. For the extraction, solvents such as water, methanol, ethanol, isopropanol can be used. Although not absolutely necessary, purification may be performed.
[0039] 2-4. Other components
The composition of the present invention can include further additional components as long as they would not affect the effect of the present invention. Example of such
additional components include vitamins, minerals, nutrient components, perfumes, antioxidants, pigments, preservatives, seasoning, sweeteners, acidulants, pH adjustors, stabilizers, isotonizing agents, emulsifiers, buffers, enrichments, and antiseptics .
[0040] 2-5. Use
Because the composition of the present invention can be expected to exert an excellent beautifying effect derived from the components such as collagen peptide, the composition of the present invention can be provided with explicitly or implicitly indicating that it is used for preventing rough skin, retention of skin moisture, protection of skin,
improvement of skin flabbiness, and is extremely useful for subjects of dry skin, rough skin, and flabby skin.
[0041] The composition of the present invention can be provided in a form of food and drink, pharmaceutical product, cosmetics, and the like. If the composition of the present invention is provided as food and drink, the composition can be provided, but not limited to, in the form of health food such as functional food products, supplements, drinking agents
(solution and suspension are included), or may be provided in the form of soft drinks, tea beverages, lactic acid bacteria beverages, and the like.
[0042] The composition of the present invention can be filled in a container. The form of the container is not
limited at all, and the composition of the present invention can be filled in sealed containers such as bottles, cans, paper packs, polyethylene terephthalate (PET) bottles,
aluminum pouches, plastic pouches and blow-molded containers.
[0043] An indication can be labeled to the container. For the description of the indication, an indication indicating the efficacy of a collagen peptide, a proteoglycan, a ceramide, or a pectin can be given. Examples of such description of the indication include uses such as for moisture retention, for skin protection, for prevention of rough skin, for improvement of flabby skin, and the like. The indication may be given to the composition itself or may be given to the container or package of the composition.
[0044] The drink of the present invention is not
particularly limited except that it is produced by using the composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin, and can be produced by a usual method. Specifically, the composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin is used as the raw material, and the steps of adding acidulants, sweeteners, and the like to the composition and sterilizing and filling the resulting product are performed to produce the drink.
Sterilization conditions may satisfy the conditions provided by the Food Sanitation Law, and various sterilization devices such as plate type heat exchangers, tube type heat exchangers, pasteurizers can be used. The filling method is not
particularly limited, and hot-pack filling, aseptic filling, and the like can be employed.
[0045] 3. Method of inhibiting generation of aggregates or precipitates
The present invention also relates to a method of
inhibiting aggregates and precipitates in the composition containing a collagen peptide, a proteoglycan, and a ceramide. The method is characteristic in a point that pectin is added to the composition. The total content of the pectin in the composition is not particularly limited, and is typically 0.05 to 0.8 w/v%, preferably 0.05 to 0.5 w/v%, more preferably 0.1 to 0.5 w/v%, yet more preferably 0.1 to 0.3 w/v% . The ratio of the proteoglycan weight to the pectin weight (proteoglycan weight : pectin weight) in the composition is not particularly limited either, and is typically 1:1 or more, preferably 1:2 or more, more preferably 1:5 or more, yet more preferably 1:10 or more, and is typically 1:800 or less, preferably 1:500 or less, more preferably 1:100 or less, yet more preferably 1:50 or less. Specifically, the ratio of the proteoglycan weight to the pectin weight (proteoglycan weight : pectin weight) in the composition is, but not limited to, 1:1 to 1:800,
preferably 1:2 to 1:500, more preferably 1:5 to 1:100, yet more preferably 1:10 to 1:50.
[0046] The method and the timing of adding a pectin to the composition are not particularly limited, as long as pectin is added in the composition at any one or more of the stages of its production. For example, the other components may be added to, or mixed with, a composition containing a pectin, or a pectin may be added to, or mixed with, a composition
containing the other components.
Example
[0047] The present invention will be described more
specifically with reference to the following Examples.
However, the present invention is not limited to these
Examples.
[0048] (Example 1)
In order to evaluate the flavor and the effect of the composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin for inhibiting precipitation that may occur with time and for inhibiting coagulation of the
precipitate, two types of beverages were produced according to the compounds shown in Table 1.
[0049] Specifically, the raw materials except the acidulant were added to water, dissolved therein, then the resulting mixture was adjusted with the acidulant to control the pH to 3.50±0.20, and the volume determination was performed. Table 1 shows the final compounding amount of the acidulant required for adjustment of the pH and the like. The obtained solution was sterilized by a plate type heat exchanger, the sterilized solution was dispensed in brown bottles by 50 mL each, and the bottles were tightly stopped to obtain beverages (1) and (2). The average molecular weight of the collagen peptide used in the Examples was 3,000, the molecular weight of the
proteoglycan derived from nasal cartilage of salmon used in the Examples was about 450,000, glucosylceramide derived from rice was used as ceramide, Piper longum was used as the plant extract, and HM pectin derived from fruit skins of citrus fruits was used as pectin.
[0050] The beverages were preserved 5°C for 4 months, and the amount of precipitate, the properties of the precipitate, and the flavor were evaluated by visual observation and by sensory tests by 3 expert panelists.
[0051] The compositions and the evaluation results are shown in Table 1.. The evaluation criteria are shown in . Table
[0052] [Table 1]
Figure imgf000022_0001
[0053] [Table 2]
Evaluation Criteria for Precipitate Amount
-: No precipitate
±: Slight amount of precipitate observed
+X: Small amount of precipitate observed
+ :. Precipitate observed
+*: Large amount of precipitate observed
++ : Precipitate remarkably observed
Evaluation Criteria for Coagulation of Precipitate
Very good: Dispersed without shaking
Good: Dispersed when lightly shaken
Fair: Dispersed when strongly shaken
Poor: Not dispersed even when strongly shaken
Evaluation Criteria for Flavor
5: Pleasant flavor and texture felt
4 : Almost no unpleasant flavor or texture felt
3: Slightly unpleasant flavor and texture felt
2: Unpleasant flavor and texture felt
1: Very unpleasant flavor and texture felt
* Average score of 4.5 to 5.0 corresponds to "Very
good", 4.0 to 4.4 corresponds to "Good", 3.0 to 3.9
corresponds to "Fair", and less than 3.0 corresponds
to "Poor".
[0054] In the beverage (1) to which pectin had not been added, a large amount of precipitate was generated, the coagulation of the precipitate was high, and it was hard to disperse. On the contrary, in the beverage (2) to which pectin had been added, good flavor was kept while the amount of the precipitate was small, the coagulation of the
precipitate was low, and it was easy to disperse.
[0055] (Example 2)
In order to evaluate the flavor of and the influence from the composition containing a collagen peptide, a proteoglycan, a ceramide, and a thickening stabilizer on precipitation that may occur with time and coagulation of the precipitate, beverages were produced according to the compounds shown in Table 3.
[0056] Specifically, the raw materials except the acidulant were added to water, dissolved therein, then the resulting mixture was adjusted with the acidulant to control the pH to 3.50+0.20, and the volume was determined to be 1,000 ml. Table 3 shows the final compounding amount of the acidulant required for adjustment of the pH and the like. The obtained solution was dispensed in brown bottles by 50 mL each, and then dip sterilization was performed to obtain beverages (3) and (16). Note that the same collagen peptide, proteoglycan, ceramide, plant extract, and pectin as those in Example 1 were used.
The beverages were preserved 5°C for 4 days, and the amount of precipitate, the properties of the precipitate, and the flavor and the texture were evaluated by visual observation and by sensory tests by 3 expert panelists.
[0057] The evaluation results are shown in Table 4. The evaluation, criteria are shown in Table 2.
[0058] In the beverages (4) and (5) to which pectin had been added, generation of precipitates were remarkably
inhibited, the coagulation of the precipitates were low, the beverages were easy to disperse, and the flavor and the texture were excellent.
[0059] [Table 3]
(3) . (4) (5) (6) (7) (8) (9)
Collagen
(average
100 100 100 100 100 100 100 molecular
weight: 3,000)
Proteoglycan 0.10 0.10 0.10 0.10 0.10 0.10 0.10
Acidulant 16 16 16 16 16 16 16
Ascorbic acid 3.6 3.6 3.6 3.6 3.6 3.6 3.6
Sucralose 0.080 0.080 0.080 0.080 0.080 0.080 0.080
Acesulfame K 0.10 0.10 0.10 0.10 0.10 0.10 0.10
Erythritol 60 60 60 60 60 60 60
Plant Extract 3.7 3.7 3.7 3.7 3.7 3.7 3.7
Ceramide 0.012 0.012 0.012 0.012 0.012 0.012 0.012
Pectin - 1.0 5.0 - - - -
Native type
- - - 0.10 0.30 - - gellan gum
Xanthan gum
- - - - - 0.10 0.50 formulation
Soybean
- - - - - - - polysaccharides
Galactomannan - - - - - - -
Proper Proper Proper Proper Proper Proper Proper Perfume
amount amount amount amount amount amount amount g/1000 ml
(10) (11) (12) (13) (14) (15) (16)
Collagen
(average
100 100 100 100 100 100 100 molecular
weight: 3,000)
Proteoglycan 0.10 0.10 0.10 0.10 0.10 0.10 0.10
Acidulant 16 16 16 16 16 16 16
Ascorbic acid 3.6 3.6 3.6 3.6 3.6 3.6 3.6
Sucralose 0.080 0.080 0.080 0.080 0.080 0.080 0.080
Acesulfame K 0.10 0.10 0.10 0.10 0.10 0.10 0.10
Erythritol 60 60 60 60 60 60 60
Plant Extract 3.7 3.7 3.7 3.7 3.7 3.7 3.7
Ceramide 0.012 0.012 0.012 0.012 0.012 0.012 0.012
Pectin - - - - - - -
Native type
- - - - - - - gellan gum
Xanthan gum
1.5 - - - - - - formulation
Soybean
- 1.0 5.0 7.5 - - - polysaccharides
Galactomannan - - - - 1.0 5.0 7.5
Proper Proper Proper Proper Proper Proper Proper
Perfume
amount amount amount amount amount amount amount g/1000 ml [0060] [Table 4]
Figure imgf000026_0001
[0061] (Example 3)
In order to evaluate the influence of the amounts of a proteoglycan and a pectin to be added on the flavor, the texture, the precipitation occurring with time, and the
coagulation of the precipitate, beverages were produced
according to the compounds (17) to (26) shown in Table 5 by a method similar to that of Example 2.
[0062] The beverages were preserved at 5°C for 8 days, and the amount of precipitates, the properties of the precipitates, and the flavor were evaluated by visual observation and
sensory tests by 3 expert panelists on day 4 and day 8.
[0063] The evaluation results are shown in Table 6. The evaluation criteria are as shown in Table 2.
[0064]
Figure imgf000027_0001
Figure imgf000028_0001
Figure imgf000028_0002
[0066] In the Examples in which proteoglycan was added at the concentration of 0.001 w/v%, the formation of precipitates were greatly inhibited by adding pectin at the concentration of 0.05 w/v% . In the Examples in which proteoglycan was. added at the concentration of 0.01 w/v%, inhibition of generation of precipitates was verified at the concentration of added pectin of 0.05 w/v%, and generation of precipitates was remarkably inhibited at the concentration of added pectin of 1.0 w/v% . Further, in the Example in which proteoglycan was added at the concentration of 0.05 w/v%, generation of precipitates tended to be inhibited better as the concentration of added pectin increased. For the flavor and the texture, in the Example in which pectin was added at the concentration of 1.0 w/v%, the viscosity was high, the flavor releasing property was poor, and the texture was heavy..
[0067] (Production Example)
By the similar method as Example 2, beverages were produced according to the compositions (27) and (28) shown in Table 7.
[0068]
[Table 7]
Figure imgf000030_0001
[0069] In the beverage (27) to which pectin had not been added, generation of precipitates was observed. On the contrary, in the beverage (28) to which pectin had been added, generation of precipitates was remarkably inhibited, the coagulation of the precipitate was low, the precipitate was easy to disperse, and further, excellent flavor and texture were obtained.
Industrial Applicability
[0070] In the present invention, a pectin is added to the composition containing a collagen peptide, a proteoglycan, and a ceramide, generation of aggregates and. precipitates can be inhibited. Because pectin is a naturally derived component, the safety is high. Therefore, according to the present invention, an excellent external appearance of the collagen peptide-containing composition can be maintained by an easy and safe method, and thus the present invention has a high industrial applicability.

Claims

[Claim 1]
A composition containing a collagen peptide, a
proteoglycan, a ceramide, and a pectin.
[Claim 2]
The composition according to claim 1, which is liquid.
[Claim 3]
The composition according to claim 1 or 2, wherein a content of the proteoglycan is 0.0001 to 0.05 w/v%.
[Claim 4].
The composition according to any one of claims 1 to 3, wherein a content of the pectin is 0.05 to 0.8 w/v%.
[Claim 5]
The composition according to any one of claims 1 to 4, wherein a ratio of the weight of the proteoglycan to the weight of the pectin (proteoglycan weight : pectin weight) is 1:1 to 1:800.
[Claim 6]
The composition according to any one of claims 1 to 5, wherein a content of the collagen peptide is 1.0 to 35 w/v%
[Claim 7]
The composition according to any one of claims 1 to 6, wherein a content of the ceramide is 0.0001 to 0.1 w/v%.
[Claim 8]
The composition according to any one of claims 2 to 7, wherein the composition has a PH of 2.5 to 5.0.
[Claim 9] The composition according to any one of claims 1 to 8, which is for oral use.
[Claim 10]
The composition according to any one of claims 1 to 9, which is for beautiful skin.
[Claim 11]
A method of inhibiting generation of an aggregate or a precipitate in a composition containing a collagen peptide, a proteoglycan, and a ceramide, the method comprising the step of adding a pectin to the composition.
[Claim 12]
The method according to claim 11, wherein an amount of the pectin added is 0.05 to 0.8 w/v% based on the total amount of the composition.
[Claim 13]
The method according to claim 11 or 12, wherein the pectin is added so that a ratio of the weight of the
proteoglycan to the weight of the pectin added (proteoglycan weight: pectin weight) is 1:1 to 1:800.
[Claim 14]
The composition according to any one of claims 1 to 10, wherein the composition is labeled indication of efficacy of the collagen peptide, the proteoglycan, the ceramide, or the pectin.
[Claim 15]
The composition according to claim 14, wherein the indication is moisture retention, skin protection, prevention of rough skin, or improvement of skin flabbiness.
[Claim 16]
A method of producing a composition containing a collagen peptide, a proteoglycan, a ceramide, and a pectin, the method comprising the steps of:
formulating a raw material containing a collagen peptide, a proteoglycan, a ceramide, and a pectin; and
sterilizing and filling the formulated composition.
[Claim 17]
The method according to claim 16, wherein an amount of the pectin added is 0.05 to 0.8 w/v% based on the total amount of the composition.
[Claim 18]
The method according to claim 16 or 17, wherein pectin is added so that a ratio of the weight of the proteoglycan to the weight of the pectin added (proteoglycan weight : pectin weight) is 1:1 to 1:800.
PCT/JP2016/052221 2016-01-20 2016-01-20 Collagen peptide-containing composition WO2017126132A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN201680083146.4A CN108697614B (en) 2016-01-20 2016-01-20 Collagen peptide-containing composition
PCT/JP2016/052221 WO2017126132A1 (en) 2016-01-20 2016-01-20 Collagen peptide-containing composition
SG11201806021QA SG11201806021QA (en) 2016-01-20 2016-01-20 Collagen peptide-containing composition
HK18116081.6A HK1256943A1 (en) 2016-01-20 2018-12-14 Collagen peptide-containing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2016/052221 WO2017126132A1 (en) 2016-01-20 2016-01-20 Collagen peptide-containing composition

Publications (1)

Publication Number Publication Date
WO2017126132A1 true WO2017126132A1 (en) 2017-07-27

Family

ID=55359687

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/052221 WO2017126132A1 (en) 2016-01-20 2016-01-20 Collagen peptide-containing composition

Country Status (4)

Country Link
CN (1) CN108697614B (en)
HK (1) HK1256943A1 (en)
SG (1) SG11201806021QA (en)
WO (1) WO2017126132A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002027957A (en) * 2000-07-17 2002-01-29 Mitsui Norin Co Ltd Liquid composition containing plant polyphenol
JP2006333730A (en) * 2005-05-31 2006-12-14 Matsutani Chem Ind Ltd Beverage stabilizing agent and stabilized beverage
JP2010001275A (en) * 2008-05-19 2010-01-07 Oriza Yuka Kk Liquid composition and drink and cosmetic produced by using the same
WO2014050922A1 (en) * 2012-09-27 2014-04-03 サントリーホールディングス株式会社 Aqueous liquid composition containing collagen peptides
WO2015156246A1 (en) * 2014-04-10 2015-10-15 サントリーホールディングス株式会社 Method for masking bitterness of composition containing collagen peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151084A1 (en) * 2012-04-04 2013-10-10 大正製薬株式会社 Aqueous liquid beverage

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002027957A (en) * 2000-07-17 2002-01-29 Mitsui Norin Co Ltd Liquid composition containing plant polyphenol
JP3416102B2 (en) 2000-07-17 2003-06-16 三井農林株式会社 Plant polyphenol-containing liquid composition
JP2006333730A (en) * 2005-05-31 2006-12-14 Matsutani Chem Ind Ltd Beverage stabilizing agent and stabilized beverage
JP5021909B2 (en) 2005-05-31 2012-09-12 松谷化学工業株式会社 Beverage stabilizer and stabilized beverage
JP2010001275A (en) * 2008-05-19 2010-01-07 Oriza Yuka Kk Liquid composition and drink and cosmetic produced by using the same
WO2014050922A1 (en) * 2012-09-27 2014-04-03 サントリーホールディングス株式会社 Aqueous liquid composition containing collagen peptides
WO2015156246A1 (en) * 2014-04-10 2015-10-15 サントリーホールディングス株式会社 Method for masking bitterness of composition containing collagen peptide

Also Published As

Publication number Publication date
SG11201806021QA (en) 2018-08-30
HK1256943A1 (en) 2019-10-04
CN108697614B (en) 2021-12-14
CN108697614A (en) 2018-10-23

Similar Documents

Publication Publication Date Title
TWI656885B (en) Aqueous liquid composition containing collagen
CN106170213B (en) Method for masking bitterness of composition containing collagen peptide
EP3287471A1 (en) Polysaccharide suitable to modulate immune response
WO2011036786A1 (en) Stress-alleviating agent comprising plant-derived polyamine-containing extract as active ingredient
EP2694030A2 (en) Cosmetic formulations
JP6530187B2 (en) Collagen peptide-containing composition
JP5468757B2 (en) Composition having fibroblast proliferation promoting ability
KR102432924B1 (en) Extract and composition comprising plant-derived collagen and mucin
JP3495712B2 (en) Food composition
KR20100023910A (en) Novel fractionation product of royal jelly, method for production of the same, and use of the same
JP2023532093A (en) Plant extract containing plant collagen and plant mucin, and method for producing the same
JP6400474B2 (en) Skin condition improver
JPWO2017038951A1 (en) Skin external preparation for reducing yellowing
TWI676485B (en) Composition containing collagen peptide
KR20150019680A (en) Composition for skin cell regeneration, anti-wrinkle and antioxidant
JP6608874B2 (en) Beauty composition
CN108697614B (en) Collagen peptide-containing composition
JP6544503B2 (en) Cosmetic composition and functional food containing collagenase inhibitor and collagenase inhibitor
JP7423179B2 (en) Foods containing polyphenols
JP5468758B2 (en) Ceramide-containing composition
JP6741401B2 (en) Method for producing ceramide-containing composition
JP6906248B2 (en) Cosmetology composition
KR102565639B1 (en) Plant derived collagen peptide composition and composition comprising the same
JP5725663B2 (en) Enzyme inhibitor
JP6211558B2 (en) Beauty composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16704715

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 11201806021Q

Country of ref document: SG

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16704715

Country of ref document: EP

Kind code of ref document: A1